Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre de la Taille

Showing results (31-40 of 389) with videos related to

Pageof 39
Sort By:
World Journal of Urology|June 4, 2020
Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent dataPierre-Jean Lamy, Xavier Rébillard, Francis Vacherot, et al.
Clinical Nuclear Medicine|November 7, 2019
Pulmonary Vein Varix Mimicking Prostate Cancer Metastasis on 68Ga-Prostate Specific Membrane Antigen-11 PET/CTBrian Sgard, Françoise Montravers, Aloÿse Fourquet, et al.
European Urology Focus|February 23, 2024
Urologists and Sustainability: The First Survey from the French Sustainability Working GroupMichael Baboudjian, Alexandre de La Taille, Eric Lechevallier, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 8, 2002
Calretinin: a valuable marker of normal and neoplastic Leydig cells of the testisDavid Augusto, Emmanuelle Leteurtre, Alexandre De La Taille, et al.
BJU International|February 28, 2007
Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?Olivier Celhay, Alexandre de la Taille, Laurent Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 18, 2004
[Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France]Alexandre de la Taille, François Desgrandchamps, Christian Saussine, et al.
Urologia Internationalis|November 21, 2007
Neuroendocrine differentiation in prostate cancer: from lab to bedsideLuca Cindolo, Monica Cantile, Francis Vacherot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 7, 2022
[Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study]Alexandre de la Taille, Quentin Chalret du Rieu, Olivia Dialla, et al.
BJU International|February 27, 2016
Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapyAlexandre de la Taille, Luis Martínez-Piñeiro, Patrick Cabri, et al.
The Prostate|August 27, 2015
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasiaAlain Latil, Marie-Thérèse Pétrissans, Jérôme Rouquet, et al.
Pageof 39

Showing results (31-40 of 389) with videos related to

Sort By:
Pageof 39
World Journal of Urology|June 4, 2020
Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent dataPierre-Jean Lamy, Xavier Rébillard, Francis Vacherot, et al.
Clinical Nuclear Medicine|November 7, 2019
Pulmonary Vein Varix Mimicking Prostate Cancer Metastasis on 68Ga-Prostate Specific Membrane Antigen-11 PET/CTBrian Sgard, Françoise Montravers, Aloÿse Fourquet, et al.
European Urology Focus|February 23, 2024
Urologists and Sustainability: The First Survey from the French Sustainability Working GroupMichael Baboudjian, Alexandre de La Taille, Eric Lechevallier, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 8, 2002
Calretinin: a valuable marker of normal and neoplastic Leydig cells of the testisDavid Augusto, Emmanuelle Leteurtre, Alexandre De La Taille, et al.
BJU International|February 28, 2007
Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?Olivier Celhay, Alexandre de la Taille, Laurent Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 18, 2004
[Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France]Alexandre de la Taille, François Desgrandchamps, Christian Saussine, et al.
Urologia Internationalis|November 21, 2007
Neuroendocrine differentiation in prostate cancer: from lab to bedsideLuca Cindolo, Monica Cantile, Francis Vacherot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 7, 2022
[Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study]Alexandre de la Taille, Quentin Chalret du Rieu, Olivia Dialla, et al.
BJU International|February 27, 2016
Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapyAlexandre de la Taille, Luis Martínez-Piñeiro, Patrick Cabri, et al.
The Prostate|August 27, 2015
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasiaAlain Latil, Marie-Thérèse Pétrissans, Jérôme Rouquet, et al.
Pageof 39